OMC

OUP Management Company Portfolio holdings

AUM $44.5M
This Quarter Return
-3.43%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$222M
AUM Growth
–
Cap. Flow
+$222M
Cap. Flow %
100%
Top 10 Hldgs %
90.61%
Holding
16
New
16
Increased
–
Reduced
–
Closed
–

Top Buys

1
IONQ icon
IonQ
IONQ
$69.3M
2
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
$28.1M
3
CNTA
Centessa Pharmaceuticals
CNTA
$26.4M
4
PMVP icon
PMV Pharmaceuticals
PMVP
$22.9M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$13.6M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 65.12%
2 Technology 31.22%
3 Industrials 3.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IONQ icon
1
IonQ
IONQ
$12.7B
$69.3M 31.22%
+4,147,081
New +$69.3M
CYT
2
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$28.1M 12.68%
+2,474,572
New +$28.1M
CNTA
3
Centessa Pharmaceuticals
CNTA
$2.25B
$26.4M 11.89%
+2,341,891
New +$26.4M
PMVP icon
4
PMV Pharmaceuticals
PMVP
$74.2M
$22.9M 10.3%
+989,232
New +$22.9M
DICE
5
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$13.6M 6.12%
+536,693
New +$13.6M
LABP
6
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$8.77M 3.95%
+1,827,478
New +$8.77M
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$8.49M 3.83%
+1,025,697
New +$8.49M
DTIL icon
8
Precision BioSciences
DTIL
$57.8M
$8.32M 3.75%
+1,123,913
New +$8.32M
EVLV icon
9
Evolv Technologies
EVLV
$1.42B
$8.12M 3.66%
+1,820,866
New +$8.12M
JBIO
10
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$7.12M 3.21%
+603,762
New +$7.12M
LENZ
11
LENZ Therapeutics
LENZ
$1.1B
$5.05M 2.28%
+406,308
New +$5.05M
SERA icon
12
Sera Prognostics
SERA
$123M
$4.41M 1.99%
+641,361
New +$4.41M
VOR icon
13
Vor Biopharma
VOR
$250M
$4.35M 1.96%
+374,714
New +$4.35M
SPRO icon
14
Spero Therapeutics
SPRO
$116M
$3.99M 1.8%
+249,070
New +$3.99M
RNAC icon
15
Cartesian Therapeutics
RNAC
$261M
$2.81M 1.27%
+862,543
New +$2.81M
QTTB icon
16
Q32 Bio
QTTB
$20.9M
$233K 0.11%
+64,000
New +$233K